Reiffel JA - Search Results

1

International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries.

Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ, Ezekowitz MD, Fonarow GC, Gersh BJ, Goldhaber S, Haas S, Hacke W, Kowey PR, Ansell J, Mahaffey KW, Naccarelli G, Reiffel JA, Turpie A, Verheugt F, Piccini JP, Kakkar A, Peterson ED, Fox KAA; GARFIELD-AF; ORBIT-AF Investigators. Steinberg BA, et al. Among authors: reiffel ja. Am Heart J. 2017 Dec;194:132-140. doi: 10.1016/j.ahj.2017.08.011. Epub 2017 Aug 24. Am Heart J. 2017. PMID: 29223431 Free article.

2

Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.

Sahar DI, Reiffel JA, Bigger JT Jr, Squatrito A, Kidwell GA. Sahar DI, et al. Among authors: reiffel ja. Am Heart J. 1989 Mar;117(3):562-8. doi: 10.1016/0002-8703(89)90729-1. Am Heart J. 1989. PMID: 2919535

3

Impact of structural heart disease on the selection of class III antiarrhythmics for the prevention of atrial fibrillation and flutter.

Reiffel JA. Reiffel JA. Am Heart J. 1998 Apr;135(4):551-6. doi: 10.1016/s0002-8703(98)70266-2. Am Heart J. 1998. PMID: 9539466 Review.

4

Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias.

Reiffel JA, Kowey PR. Reiffel JA, et al. Am J Cardiol. 2000 May 1;85(9):1151-3, A10. doi: 10.1016/s0002-9149(00)00715-3. Am J Cardiol. 2000. PMID: 10781771

5

Drug choices in the treatment of atrial fibrillation.

Reiffel JA. Reiffel JA. Am J Cardiol. 2000 May 25;85(10A):12D-19D. doi: 10.1016/s0002-9149(00)00902-4. Am J Cardiol. 2000. PMID: 10822036 Review.

6

Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation?

Reiffel JA. Reiffel JA. Curr Opin Cardiol. 2004 Jan;19(1):58-63. doi: 10.1097/00001573-200401000-00012. Curr Opin Cardiol. 2004. PMID: 14688636 Review.

7

Antiarrhythmic drug therapy for atrial fibrillation: are the guidelines guiding clinical practice?

Reiffel JA, Naccarelli GV. Reiffel JA, et al. Clin Cardiol. 2006 Mar;29(3):97-102. doi: 10.1002/clc.4960290303. Clin Cardiol. 2006. PMID: 16596830 Free PMC article. Review.

8

New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?

Morrow JP, Cannon CP, Reiffel JA. Morrow JP, et al. Among authors: reiffel ja. Am Heart J. 2007 Nov;154(5):824-9. doi: 10.1016/j.ahj.2007.06.041. Am Heart J. 2007. PMID: 17967585 Review.

9

Device therapies in the post-myocardial infarction patient with left ventricular dysfunction.

Kadish AH, Reiffel JA, Naccarelli GV, DiMarco JP. Kadish AH, et al. Among authors: reiffel ja. Am J Cardiol. 2008 Sep 8;102(5A):29G-37G. doi: 10.1016/j.amjcard.2008.06.008. Am J Cardiol. 2008. PMID: 18722189 Review.

10

A contemporary look at classic trials in atrial fibrillation: what do they really show and how might they apply to future therapies?

Reiffel JA. Reiffel JA. Am J Cardiol. 2008 Sep 22;102(6A):3H-11H. doi: 10.1016/j.amjcard.2008.06.024. Am J Cardiol. 2008. PMID: 18790109 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters